Company Overview and News

0
Gujarat Gas Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-05 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GUJGAS 539336

0
Gujarat Gas Limited - Reply to Clarification- Financial results

2018-05-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GUJGAS 539336

0
Gujarat Gas Limited - Clarification - Financial Results

2018-05-15 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GUJGAS 539336

30
Market Live: Sensex trades lower, Nifty hovers around 10800; midcaps, auto stocks fall

2018-05-14 moneycontrol
Some weakness is now seen on the D-Street as it gets ready for the outcome of Karnataka assembly polls on Tuesday. The Sensex is down over 50 points, while the Nifty is trading around 10,780-levels. Midcaps have further extended their fall, pharma and PSU banks have trimmed some of the gains. Auto stocks too continued to trade lower. Dr Reddy’s Labs, NTPC, and SBI were the top gainers, while Tata Motors, M&M, Titan and Indiabulls Housing were the top losers.
MAHLIFE 500325 500820 RELIANCE 539336 HCTHY HINDUNILVR 532218 BHRQY ASIANPAINT 533278 532313 MGEVF SOUTHBANK 500470 532121 532483 ALLCARGO RIGD 500696 532281 500356 500570 BHARTIARTL TATAMOTORS CLNDY RLNIY 524669 IBN 532749 RAMANEWS CNRYY 532454 HESTERBIO GUJGAS ICICIBANK TTST TATASTEEL TATLY 532174 HCLTECH CANBK DENABANK COALINDIA TTM

0
Gujarat Gas Limited - Dividend

2018-05-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GUJGAS 539336

24
Market Live: Nifty opens above 10,800, Sensex flat after Karnataka exit polls

2018-05-14 moneycontrol
Market Update: The market is trading in a tight range of around 20 points on the Nifty. Traders prefer to await Karnataka elections results before taking any big positions as exit polls announced on Saturday indicated hung assembly.
MAHLIFE 500820 500469 539336 HCTHY HINDUNILVR FEDA 532218 ASIANPAINT 533278 532313 MGEVF SOUTHBANK 500470 532483 ALLCARGO FEDS 500696 532281 520086 500570 FEDERALBNK TATAMOTORS CLNDY IBN 532749 FDBAY CNRYY GUJGAS ICICIBANK TTST TATASTEEL TATLY 532174 HCLTECH SICAL CANBK COALINDIA TTM

0
Gujarat Gas Limited - Financial Result Updates

2018-05-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GUJGAS 539336

6
Canara, 4 other banks’ results on Friday

2018-05-10 thehindubusinessline
Nearly 60 companies, including Aarti Ind, AB Fashion, Allahabad Bank, BSL, Canara Bank, Dena Bank, Gillette, Graphite, Glaxo Consumer, Gujarat Gas, Havells India, Kesoram, Khadim, Lakshmi Finance, Neuland Labs, New India Assurance, Oracle, P&G, Puravankara, Relaxo Footwear, Solar Ind, Sun TV, Tata Global Beverages, TVS Electronics, VST Tillers, UCO Bank and United Bank will declare their Q4 and full-year results on Friday for the period ending March.
UDBKL 500800 TTAZF 539336 UBLS 532513 TTAEY TGBL 532121 532483 UBLA 532480 517354 HVLQY TGBA ALBK 532505 CNRYY TVSELECT GUJGAS HAVELLS UCOBANK CANBK DENABANK TATAGLOBAL

0
Gujarat Gas Limited - Trading Window

2018-05-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GUJGAS 539336

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...